SS

Subhashini Sinha

Active Director Designated Partner DIN 10037915
DIN 10037915 First appointment Jan 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Subhashini Sinha

Data last updated:

Subhashini Sinha is a Designated Partner at Welkin Children Hospital And Research Centre Llp (since 2023). The company operates in Healthcare.

DIN 10037915
Primary Designation Designated Partner
Industry Healthcare
First Appointment 10 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Jan 20232023Active

Board colleagues of Subhashini Sinha

NameDINCompanyDesignation
Prabhat Sinha10037914Welkin Children Hospital And Research Centre LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Welkin Children Hospital And Research Centre Llp
Premium access

Shareholding and investment profile for Subhashini Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subhashini Sinha

Subhashini Sinha currently holds 1 directorship: Welkin Children Hospital And Research Centre Llp (Designated Partner, since 10 Jan 2023).

Subhashini Sinha was first appointed on 10 Jan 2023 as Designated Partner at Welkin Children Hospital And Research Centre Llp.

The current boards of Subhashini Sinha's companies include Prabhat Sinha (Welkin Children Hospital And Research Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available